General Archive

-
News releases
LifeArc funds home monitoring trials for people with chronic respiratory conditions
Trials will examine the impact of home monitoring and machine learning decision support algorithms for people with CF and bronchiectasis.
-
Articles & blogs, Ventures funding
AbbVie acquires LifeArc portfolio company DJS Antibodies
AbbVie will pay DJS shareholders approximately $255 million in cash at closing for the acquisition of DJS
-
News releases
Promising new asthma medicine ready to enter early clinical trials
LifeArc scientists instrumental to the development of the world’s first anti-IL17BR antibody, now being trialled as a treatment for severe…
-
News releases
Pandemic Science Hub to develop better drugs to fight lung disease
New, multi-million pound research programme at the University of Edinburgh will develop treatments for lung infections
-
Rising to the challenge of COVID-19
While the development of COVID-19 vaccines has garnered much attention, scientists have also been looking at repurposed medicines as an…
-
How to kill a virus: LifeArc’s role in shaping the UK’s COVID-19 response
In 2020 the UK Government, supported by UK Research and Innovation and the National Institute for Health and Research, launched…
-
LifeArc scientists play pivotal role in the search for a COVID-19 antibody therapy
While much attention in the race for treatments for Covid-19 has been on the development of new vaccines, scientists have…